Session Details
[Pj-062]Japanese Poster Session 062 Dementia (Alzheimer's disease 4)
Fri. May 23, 2025 5:15 PM - 6:35 PM JST
Fri. May 23, 2025 8:15 AM - 9:35 AM UTC
Fri. May 23, 2025 8:15 AM - 9:35 AM UTC
ポスター会場(大阪国際会議場3F イベントホール)
Chair: Ryoko Ihara（Tokyo Metropolitan Institute for Geriatrics and Gerontology, Japan）
[Pj-062-1]Interprofessional work and clinical courses around the administration of lecanemab
Hiroki Takeuchi1,2, Kenji Yamamoto1,2, Makiko Ota1, Kyoko Hosokawa1, Kazuma Saka3, Kyoko Tsunamoto3,4, Asuka Yatagawa3,4, Yukiko Kida3, Keiko Hamamura3,5, Tomoko Saida3, Masahiro Funahashi6, Hiroshi Sugiyama1 (1.Dept. of Neurology, NHO Minami Kyoto Hospital, Japan, 2.Clinical Research Center, NHO Minami Kyoto Hospital, Japan, 3.Dept. of Nursing, NHO Minami Kyoto Hospital, Japan, 4.Dept. of Clinical Trial Management, NHO Minami Kyoto Hospital, Japan, 5.Dept. of Regional Medical Coordination, NHO Minami Kyoto Hospital, Japan, 6.Dept. of Administration, NHO Minami Kyoto Hospital, Japan)
[Pj-062-2]Care partners' perceptions of amyloid targeting therapy for Alzheimer's disease with stopping dosing
Sadao Katayama1, Masashi Tsujimoto2, Keisuke Suzuki2, Kaname Ueda3, Manaka Sato3, Kanako Shimoura4, Shintaro Suo4, Naohisa Hatakeyama3 (1.Katayama Medical Clinic, Japan, 2.National Center for Geriatrics and Gerontology, Japan, 3.Eli Lilly Japan K.K., Japan, 4.Mebix, Inc., Japan)
[Pj-062-3]6-month follow-up data of Alzheimer's disease patients treated with Lecanemab at our hospital
Kai Funakawa1, Ryoko Ihara1, Masanori Kurihara1, Keiko Hatano1, Taro Bannai3, Yasushi Nishina1, Fumio Suzuki2, Aya M Tokumaru2, Kenji Ishii4, Atsushi Iwata1 (1.Department of Neurology, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Japan, 2.Department of Radiology, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Japan, 3.Department of Neurology, Tokyo Teishin Hospital, Japan, 4.Team for Neuroimaging Research, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Japan)
[Pj-062-4]CSF p-Tau181 levels may predict therapeutic effects of anti-amyloid beta antibody treatment
Yuki Naeshiro, Maika Yoshida, Fukiko Morii, Takashi Kasai (Kyoto Prefectural University of Medicine, Japan)
[Pj-062-5]Serum Cortisol Correlates with CSF beta-amyloid and p-tau in Non-Alzheimer's disease patients
Sakiho Ueda1, Yukiko Kusumoto1, Genki Akahori1, Takafumi Wada1, Mizuki Matsumoto2, Ryosuke Takahashi3, Riki Matsumoto1, Akira Kuzuya1 (1.Department of Neurology, Kyoto University Graduate School of Medicine, Japan, 2.Midorikawa Clinic, Japan, 3.Kyoto University Research Administration Center, Japan)
[Pj-062-6]The role and issues of a local hospital introducing amyloid-beta targeting therapy
Motoharu Kawai, Shiori Takahashi, Masayuki Kato, Hideshi Hashiguchi, Takashi Kanda (Neuromuscular Center Yoshimizu Hospital, Japan)
[Pj-062-7]Prospective Database Study for Prognostic Modeling of Anti-AB Antibody Therapy in AD: HIRAPAR study
Tatsuya Doyama1, Shuhei Ikeda1, Masayasu Morikawa1, Aya Murakami1, Rie Tohge2, Masataka Nakamura1, Yoshiteru Takekita3, Hiroaki Kurokawa4, Keita Utsunomiya5, Makio Takahashi6, Takayuki Kondo2, Noboru Tanigawa4, Masaki Kato3, Yusuke Yakushiji1 (1.Department of Neurology, Kansai Medical University, Japan, 2.Department of Neurology, Kansai Medical University Medical Center, Japan, 3.Department of Neurosychiatry, Kansai Medical University, Japan, 4.Department of Radiology, Kansai Medical University, Japan, 5.Department of Radiology, Kansai Medical University Medical Center, Japan, 6.Department of Neurological Intractable Diseases, Kansai Medical University, Japan)